These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22819262)

  • 1. The search for genetic mouse models of prodromal Parkinson's disease.
    Smith GA; Isacson O; Dunnett SB
    Exp Neurol; 2012 Oct; 237(2):267-73. PubMed ID: 22819262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
    Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
    Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal infection triggers Parkinson's disease-like symptoms in Pink1
    Matheoud D; Cannon T; Voisin A; Penttinen AM; Ramet L; Fahmy AM; Ducrot C; Laplante A; Bourque MJ; Zhu L; Cayrol R; Le Campion A; McBride HM; Gruenheid S; Trudeau LE; Desjardins M
    Nature; 2019 Jul; 571(7766):565-569. PubMed ID: 31316206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative expression proteomics and phosphoproteomics profile of brain from PINK1 knockout mice: insights into mechanisms of familial Parkinson's disease.
    Triplett JC; Zhang Z; Sultana R; Cai J; Klein JB; Büeler H; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):750-65. PubMed ID: 25626353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In search of early neuroradiological biomarkers for Parkinson's Disease: Alterations in resting state functional connectivity and gray matter microarchitecture in PINK1 -/- rats.
    Cai X; Qiao J; Knox T; Iriah S; Kulkarni P; Madularu D; Morrison T; Waszczak B; Hartner JC; Ferris CF
    Brain Res; 2019 Mar; 1706():58-67. PubMed ID: 30389398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine induced neurodegeneration in a PINK1 model of Parkinson's disease.
    Gandhi S; Vaarmann A; Yao Z; Duchen MR; Wood NW; Abramov AY
    PLoS One; 2012; 7(5):e37564. PubMed ID: 22662171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PINK1 and Parkin complementarily protect dopaminergic neurons in vertebrates.
    Matsui H; Gavinio R; Asano T; Uemura N; Ito H; Taniguchi Y; Kobayashi Y; Maki T; Shen J; Takeda S; Uemura K; Yamakado H; Takahashi R
    Hum Mol Genet; 2013 Jun; 22(12):2423-34. PubMed ID: 23449626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of Mitochondrial Homeostasis: The Role of PINK1 in Parkinson's Disease.
    Vizziello M; Borellini L; Franco G; Ardolino G
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of PINK1 enhances neurodegeneration in a mouse model of Parkinson's disease triggered by mitochondrial stress.
    Moisoi N; Fedele V; Edwards J; Martins LM
    Neuropharmacology; 2014 Feb; 77():350-7. PubMed ID: 24161480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditional deletion of Ndufs4 in dopaminergic neurons promotes Parkinson's disease-like non-motor symptoms without loss of dopamine neurons.
    Choi WS; Kim HW; Tronche F; Palmiter RD; Storm DR; Xia Z
    Sci Rep; 2017 Mar; 7():44989. PubMed ID: 28327638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic Neurons Exhibit an Age-Dependent Decline in Electrophysiological Parameters in the MitoPark Mouse Model of Parkinson's Disease.
    Branch SY; Chen C; Sharma R; Lechleiter JD; Li S; Beckstead MJ
    J Neurosci; 2016 Apr; 36(14):4026-37. PubMed ID: 27053209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for early and progressive ultrasonic vocalization and oromotor deficits in a PINK1 gene knockout rat model of Parkinson's disease.
    Grant LM; Kelm-Nelson CA; Hilby BL; Blue KV; Paul Rajamanickam ES; Pultorak JD; Fleming SM; Ciucci MR
    J Neurosci Res; 2015 Nov; 93(11):1713-27. PubMed ID: 26234713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson's disease.
    Song B; Feldmann JW; Cao S; Feitosa M; Kong Y; Kim W; Schweitzer A; Leblanc P; Schweitzer JS; Kim KS
    Neurobiol Dis; 2022 Aug; 170():105777. PubMed ID: 35636646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the pathology of prodromal non-motor symptoms olfactory deficit and depression in Parkinson's disease: clues to early diagnosis and effective treatment.
    Bang Y; Lim J; Choi HJ
    Arch Pharm Res; 2021 Jun; 44(6):588-604. PubMed ID: 34145553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion tensor imaging and olfactory identification testing in early-stage Parkinson's disease.
    Rolheiser TM; Fulton HG; Good KP; Fisk JD; McKelvey JR; Scherfler C; Khan NM; Leslie RA; Robertson HA
    J Neurol; 2011 Jul; 258(7):1254-60. PubMed ID: 21287185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial dysfunction in genetic animal models of Parkinson's disease.
    Trancikova A; Tsika E; Moore DJ
    Antioxid Redox Signal; 2012 May; 16(9):896-919. PubMed ID: 21848447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prodromal sensory neuropathy in Pink1
    Valek L; Tran B; Wilken-Schmitz A; Trautmann S; Heidler J; Schmid T; Brüne B; Thomas D; Deller T; Geisslinger G; Auburger G; Tegeder I
    Neuropathol Appl Neurobiol; 2021 Dec; 47(7):1060-1079. PubMed ID: 33974284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cav1.3 channels control D2-autoreceptor responses via NCS-1 in substantia nigra dopamine neurons.
    Dragicevic E; Poetschke C; Duda J; Schlaudraff F; Lammel S; Schiemann J; Fauler M; Hetzel A; Watanabe M; Lujan R; Malenka RC; Striessnig J; Liss B
    Brain; 2014 Aug; 137(Pt 8):2287-302. PubMed ID: 24934288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LRRK2 BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit function.
    Sloan M; Alegre-Abarrategui J; Potgieter D; Kaufmann AK; Exley R; Deltheil T; Threlfell S; Connor-Robson N; Brimblecombe K; Wallings R; Cioroch M; Bannerman DM; Bolam JP; Magill PJ; Cragg SJ; Dodson PD; Wade-Martins R
    Hum Mol Genet; 2016 Mar; 25(5):951-63. PubMed ID: 26744332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repulsive Guidance Molecule a (RGMa) Induces Neuropathological and Behavioral Changes That Closely Resemble Parkinson's Disease.
    Korecka JA; Moloney EB; Eggers R; Hobo B; Scheffer S; Ras-Verloop N; Pasterkamp RJ; Swaab DF; Smit AB; van Kesteren RE; Bossers K; Verhaagen J
    J Neurosci; 2017 Sep; 37(39):9361-9379. PubMed ID: 28842419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.